Vous pouvez maintenant accéder à la version de decembre 2024 du Répertoire canadien des médicaments à partir de Terminology Gateway et du serveur terminologique, à des fins de consultation ou d’implantation.
En savoir plus >
If you have general comments or questions about the PS-CA Interoperability, please feel free to post in this thread. We will have our subject matter experts available to respond. This is also a great way to spark conversations with other stakeholders about how they are addressing particular topics.
Please note that if you have specific questions on the Pan-Canadian Patient Summary Interoperability Specifications v0.1 we invite you to submit comments to Cette adresse courriel est protégée contre les robots spammeurs. Vous devez activer le JavaScript pour la visualiser. using the PS-CA Public Review Comments PS-CA v0.1 spreadsheet, available
here
. We kindly ask that each organization submit all comments within one spreadsheet submission. The timeline for Public Review is: November 24, 2021 – December 17, 2021.